Author

Shehna Sharaf

Observed name: Sharaf Shehna

Institution: University of Hyderabad

Observed institutions: University of Kerala, Jawaharlal Nehru Tropical Botanic Garden and Research Institute, University of Hyderabad, HLL Lifecare (India), Institute for Experimental Endocrinology and Oncology, National Research Council

ORCID: 0000-0002-9380-0300

Observed ORCID: 0000-0002-9380-0300

OpenAlex ID: A5021850141

Anti-cancer, anti-bacterial and anti-oxidant properties of an active fraction isolated from Curcuma zedoaria rhizomes

2021 · Sharaf Shehna, S Sreelekshmi, et al. · Phytomedicine Plus · 16

Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence

2025 · Divya Vishambhar Kumbhakar, Lucky Thakkar, et al. · Frontiers in Oncology · 9

Comparative differential cytotoxicity of clinically used SERMs in human cancer lines of different origin and its predictive molecular docking studies of key target genes involved in cancer progression and treatment responses

2021 · Lakshmi S, Shanitha A, et al. · Current Research in Pharmacology and Drug Discovery · 8

Evaluation of molecular effects associated with apoptosis, tumour progression, angiogenesis and metastasis by a novel combination of drugs with ormeloxifene in triple negative breast cancer cells

2024 · Shehna Sharaf, Sreelekshmi S, et al. · Exploration of Targeted Anti-tumor Therapy · 4

In Vitro Anti Angiogenetic Activity of Traditional Plants Saraca asoca, Glycyrrhizia glabra and Curcuma longa Beneficial for Endometriosis Treatment

2024 · Reshmi Nair, Shehna Sharaf, et al. · Indian Journal of Pharmaceutical Sciences · 1

COVID-19: global pandemic with divergent waves: an exigent public health concern worldwide with special context to Indian scenario

2022 · Shehna Sharaf, Faisal Moossa Athikkavil, et al. · International Journal of Community Medicine and Public Health · 1

Works count: 6

Citation count: 39

H-index: 4

I10-index: 1